K. Ogata

A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy

J. J. Padilla, C. Palermo, M. Pane, 2018, Neuromuscular Disorders.

P.441 Tubular aggregate myopathy with dystrophic features

I. Nishino, E. Koshimizu, S. Noguchi, 2017, Neuromuscular Disorders.

Winter Activity of Ants in an Urban Area of Western Japan

M. Rahman, Shingo Hosoishi, K. Ogata, 2019, Sociobiology.

Safety and immunogenicity of mRNA COVID‐19 vaccine in inpatients with muscular dystrophy

Toshio Saito, T. Matsumura, Tomoko Saito, 2022, Muscle & nerve.

A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy

C. Palermo, M. Pane, E. Mercuri, 2018, Neuromuscular Disorders.